Published in Medical Letter on the CDC and FDA, July 4th, 2004
Arixtra is already indicated in the United-States for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism in patients undergoing hip fracture...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA